BODB11 Dips: Why the Unit Price Dropped and the Discount Widened on the B3 Relevance8,0
Intermediate PTENES

BODB11 Dips: Why the Unit Price Dropped and the Discount Widened on the B3

The fund ramped up leverage to 123.5% and stretched its duration to 7.6 years, amplifying volatility and creating a 9% discount to net asset value.

The market value of the infrastructure fund BODB11 has dropped to R$ 7.08, opening up a 9% discount relative to its net asset value. Behind this sell-off on the B3 is not an immediate default, but a deliberate choice by management: to increase leverage to 123.5% and stretch the average maturity of its holdings to 7.6 years, which turbocharges the unit's price volatility.

What Is BODB11's Real Value Today?

The infrastructure fund BODB11 currently has a net asset value of R$ 7.78 per unit, but ended October trading at R$ 7.47 and continued to fall on the B3 until hitting R$ 7.08 in November. This means an investor is currently buying R$ 100 in assets for roughly R$ 91—a 9% discount compared to the 3% discount observed when the unit was hovering around R$ 7.94.

This widening discount does not stem from immediate cash flow surprises. The monthly distribution remained at R$ 0.09 per unit—identical to the level maintained in previous months, which our site has been tracking. This payout corresponds to an annualized tax-exempt dividend yield of 15.5% based on the October close of R$ 7.47, a rate that climbs to over 15.2% net per year at the recent price of R$ 7.08.

Previous Thesis P/NAV 0.97 Unit at R$ 7.94 (3% discount)
→
Current Picture P/NAV 0.91 Unit at R$ 7.08 (9% discount)

What changed substantially between our last review and the newly released management report was not the cash distribution deposited into accounts, but the fund's sensitivity to market interest rates. Bocaina Capital's management team took advantage of market windows to ramp up purchases, but did so by taking on more operational debt and extending maturities.

Why Did the Unit Price Fall If the Dividend Did Not Change?

The answer lies in mark-to-market pricing combined with two portfolio shifts: higher reverse repo leverage and longer maturities. Through September, the fund had 108.4% of its net asset value allocated to tax-exempt infrastructure debentures (debêntures incentivadas), operating with roughly 8% gross leverage via reverse repurchase agreements (compromissadas). By the end of October, that allocation to private credit securities jumped to 123.5%, spread across 80 positions (up from 66 assets previously).

By carrying 123.5% of its NAV in private credit, the fund operates with nearly a quarter of its size financed via reverse repos. This structure amplifies carry gains when interest rates fall or spreads tighten, but punishes net asset value with doubled-force when rates rise. The second driver was the average duration, which moved from 5.7 years to 7.6 years.

Credit Allocation (Leverage) 123.5% (was 108.4%)
Average Portfolio Duration 7.6 years (was 5.7)

The longer a security's duration, the more its price swings with every 0.10 percentage point shift in the NTN-B real interest rate curve. By jumping to 7.6 years of average duration with 123.5% exposure, BODB11 began behaving like an ultra-long, leveraged debenture portfolio. In practice, any widening in Treasury IPCA+ yields drives down the asset value faster than before, hurting the sentiment of investors trading units on the B3.

This phenomenon is not exclusive to this asset: the infrastructure credit sector has been undergoing a generalized repricing. We have seen similar price pressure among secondary market peers, as reported in our recent report on BDIF11 and in the forced selling we analyzed when CPTI11 dropped following its monthly report.

What Does the October Management Report Reveal About Portfolio Risk?

The fund closed October with a net asset value of approximately R$ 510 million and 23,998 unitholders. Although the investor base remains broad, sectoral diversification reached 11 infrastructure segments to accommodate the 80 portfolio positions.

Operational Metric Previous Thesis October 2026 Report Change
Private Credit Exposure 108.4% 123.5% +15.1 pp
Portfolio Duration 5.7 years 7.6 years +1.9 years
Number of Positions 66 securities 80 securities +14 assets
Market Unit Price R$ 7.94 R$ 7.47 (R$ 7.08 current) -10.8% cumulative
Discount to NAV (P/NAV) 0.97 (3% disc.) 0.91 (9% disc.) Worsened by 6.0 pp

The new document does not alter the caution we maintained regarding concentration in major issuers: Alares remains the primary single-issuer risk in the portfolio, accounting for more than 13% of NAV across its issuances. The operational novelty is that, to maintain high payouts for unitholders, the fund opted to expand its range to 80 securities and maintain heavy leverage rather than trim positions to await a more favorable macroeconomic environment.

What This Means for Unitholders

If you bought BODB11 looking for a conservative fixed-income product, the fund does not deliver that. Screen volatility has increased because the fund leveraged up to buy longer-dated bonds. On the other hand, for investors focused exclusively on the R$ 0.09 monthly payout, cash flow remains backed by the debenture carry, with a net annual return above 15% at current prices. The risk lies in defaults among mid-sized borrowers and the financing costs of reverse repos if the Selic rate remains elevated for longer.

Is BODB11 Worth It at the Current Price?

The price of R$ 7.08 bakes in a meaningful discount to NAV for a portfolio predominantly rated A and AA. However, investors must recognize that BODB11 has become a more tactical bet: if inflation decelerates and forward interest rates compress, the capital gains driven by the 7.6-year duration and 123.5% leverage will be substantial.

If credit stress and high interest rates persist, market prices will continue to suffer from sharp swings. Our recommendation remains accumulation only for moderate portfolio allocations, without concentrating capital in a single private credit vehicle. You can follow more operational details of the fund in our complete BODB11 analysis.

1

Reverse repo leverage level — Watch whether the 123.5% allocation begins to scale back if CDI financing costs squeeze carry margins.

2

Market discount (P/NAV) — Monitor whether the discount breaches 10% (units below R$ 7.00), which would make the carry even more attractive but signal rising risk aversion in private credit.

3

Sustainability of the R$ 0.09 payout — Track monthly reports to confirm whether accounting and cash results cover distributions without burning through accumulated reserves.

Verdict: Is It Worth Buying BODB11 at a 9% Discount?

BODB11 remains an attractive alternative for generating tax-exempt income, but the October report made the fund riskier than it was at the beginning of the year. With 123.5% of NAV allocated and duration stretched to 7.6 years, investors are buying a high carry with significant interest rate sensitivity. It is worth accumulating gradually in small tranches, knowing that the unit price will continue to fluctuate.